Prescription drug costs under review in Maryland

The Maryland Prescription Drug Affordability Board met for the first time on Monday. The creation of the board was approved last year to address increasing prescription drug prices.

The Maryland Prescription Drug Affordability Board met for the first time on Monday. The creation of the board was approved last year to address increasing prescription drug prices. The five-member board will conduct research on prescription drug costs, with a study expected later this year set to focus on generic drug markets and how medication prices affect insurance premiums. The board is also required to conduct an annual study on trends in drug prices. One option available to the board would be to recommend establishing upper-payment limits to make expensive medications more affordable for state and local governments. Elected officials would have to approve such a recommendation, which would have to be submitted to the state legislature's Policy Committee by July 1, 2021.